A detailed history of Uss Investment Management LTD transactions in Biogen Inc. stock. As of the latest transaction made, Uss Investment Management LTD holds 37,082 shares of BIIB stock, worth $5.53 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
37,082
Previous 35,742 3.75%
Holding current value
$5.53 Million
Previous $8.29 Million 13.25%
% of portfolio
0.05%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$189.07 - $236.8 $253,353 - $317,312
1,340 Added 3.75%
37,082 $7.19 Million
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $264,060 - $328,093
1,386 Added 4.03%
35,742 $8.29 Million
Q1 2024

May 15, 2024

BUY
$212.02 - $267.71 $877,126 - $1.11 Million
4,137 Added 13.69%
34,356 $7.41 Million
Q3 2023

Nov 14, 2023

BUY
$253.3 - $285.89 $435,422 - $491,444
1,719 Added 6.03%
30,219 $7.77 Million
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $113,912 - $129,798
444 Added 1.58%
28,500 $7.92 Million
Q3 2022

Nov 08, 2022

SELL
$194.69 - $268.46 $1.61 Million - $2.23 Million
-8,292 Reduced 22.81%
28,056 $7.49 Million
Q2 2022

Aug 12, 2022

SELL
$187.54 - $223.02 $512,359 - $609,290
-2,732 Reduced 6.99%
36,348 $7.42 Million
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $1.05 Million - $1.33 Million
5,437 Added 16.16%
39,080 $8.23 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $1.75 Million - $2.28 Million
6,168 Added 22.45%
33,643 $9.52 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $1.68 Million - $2.52 Million
-7,100 Reduced 20.54%
27,475 $6.72 Million
Q2 2020

Aug 11, 2020

BUY
$258.66 - $342.55 $1.24 Million - $1.64 Million
4,797 Added 16.11%
34,575 $9.24 Million
Q1 2020

May 11, 2020

BUY
$268.85 - $341.04 $6.1 Million - $7.73 Million
22,678 Added 319.41%
29,778 $9.42 Million
Q4 2019

Feb 06, 2020

BUY
$220.06 - $304.07 $1.56 Million - $2.16 Million
7,100 New
7,100 $2.11 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.